Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction
Yujiao Shi, Chen Yang, Wen Qiao, Yong Cheng Liu, Si Yu Liu, Guo Dong
Topics & Concepts
MedicineHeart failure with preserved ejection fractionFibrosisInternal medicineHeart failureValsartanEjection fractionMyocardial fibrosisVentricular remodelingInflammationEndocrinologyMuscle hypertrophyCardiologyCardiac fibrosisBlood pressureCardiovascular Function and Risk FactorsHeart Failure Treatment and ManagementCardiac Fibrosis and Remodeling